Caricamento...
Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
BACKGROUND: This study sought to investigate the safety of 3‐month dual antiplatelet therapy (DAPT) in patients receiving ultrathin sirolimus‐eluting stents with biodegradable polymer (Orsiro). METHODS AND RESULTS: The SMART‐CHOICE (Smart Angioplasty Research Team: Comparison Between P2Y12 Antagonis...
Salvato in:
| Pubblicato in: | J Am Heart Assoc |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955499/ https://ncbi.nlm.nih.gov/pubmed/33345567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.018366 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|